Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro injection is a once-weekly under-the-skin injection of tirzepatide, made by Eli Lilly and given with a pre-filled KwikPen. Each pen holds four weekly doses. It's licensed in the UK for weight management and type 2 diabetes, and it's prescription-only, so a prescriber has to assess you first. The rest of this page walks through what's actually in the pen, how a weekly injection works in practice, and the safety points worth knowing before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before the routine, the substance. Each Mounjaro injection delivers tirzepatide, the single active ingredient. What makes it different from most weight-loss medicines is that tirzepatide works on two gut-hormone receptors at once, GIP and GLP-1, rather than one. That dual action influences appetite and blood-sugar control, slows how quickly your stomach empties, and helps you feel fuller for longer. It's the only dual-agonist of its kind licensed in the UK, according to the NHS guidance on tirzepatide.
Alongside the tirzepatide, the solution contains inactive ingredients that keep it stable and comfortable to inject, plus water for injections. The exact list, along with anything you'd need to know about allergies, sits in the patient information leaflet inside every box. If you want the full formulation detail, the Mounjaro SmPC on the eMC is the definitive source.
People often ask what the liquid looks like: it should be clear and colourless to slightly yellow. If it's cloudy, discoloured or has particles floating in it, that pen shouldn't be used. The medicine comes ready-mixed in the KwikPen, so there's no measuring or drawing up. You can read more about what the Mounjaro injection actually is if you're weighing it up against other options. Because it's a prescription-only medicine, none of this replaces a clinical assessment.
A Mounjaro injection in the UK is taken once every seven days, on the same day each week where you can manage it. Many people pick a day that's easy to remember, then set a phone reminder. If life gets busy, the timing can flex a little, but the details of missed or moved doses always belong with your prescriber and the leaflet, never a guess.
The injection goes into the fatty layer just under the skin, not into muscle. The KwikPen is designed for that: you don't see or handle a loose needle in the same way you might picture. Our page on how to use the Mounjaro pen covers the mechanics properly, and there's a separate guide on how to inject Mounjaro for anyone nervous about their first go. That nervousness is normal, by the way. Most people find the first injection is the hardest, and it isn't nearly as bad as they'd built it up to be.
The dose you inject depends on where you are in your treatment. Everyone begins at 2.5mg. That first pen isn't really about weight loss at all; its job is to let your system settle and reduce the chance of feeling sick. From there your prescriber decides whether and when to step up, usually in four-week intervals.
Three areas are licensed for the Mounjaro injection: the abdomen, the thigh and the upper arm. The stomach is the most popular, partly because it's easy to reach and pinch, but the choice is genuinely yours within those three. What matters more than the spot is moving it around.
Rotating sites each week reduces the risk of lumps, soreness or skin changes from injecting the same patch repeatedly. A simple approach is to keep to one general area for a while, then move to a fresh point within it each time. If you'd like the detail, our guides on the best Mounjaro injection sites and specifically the thigh as an injection site lay out the practicalities. Some people also ask whether the upper arm is easier or harder than the stomach.
A small tip our prescribers hear works well: stay a few centimetres away from your belly button, and avoid any area that's bruised, tender, red or scarred. If you're comparing the two most common spots, we've written about whether stomach or thigh is better. There's no wrong answer among the licensed sites; comfort and consistency are what count.
The Mounjaro KwikPen arrives ready to use, with no mixing. Before injecting, you check the medicine looks right, attach a fresh needle if your pen type requires one, and follow the leaflet's preparation steps. A clean site helps, which is why some people wipe with an alcohol swab and let it dry first.
Storage is where people slip up. Unopened pens live in the fridge at 2 to 8°C. There's a limited window during which a pen can be kept at room temperature, but the exact figures vary, so always read them off your leaflet rather than relying on memory. Our page on how long Mounjaro lasts in the fridge goes into this, and there's a fuller guide to storing the Mounjaro injection if you travel.
Everyday reality: most people keep the pen in the fridge door next to the milk, which is fine as long as it doesn't freeze. A pen that has frozen should never be used. Keeping the box helps too, since it shields the pen from light. If you'd rather see the device itself before you start, we've documented the Mounjaro KwikPen in detail.
What happens after the injection matters as much as the injection itself. Used pens and any needles are sharps, and they don't go in the household bin or recycling. The safe route is a dedicated sharps container, which you seal and dispose of according to your local council's arrangements.
If your pen uses separate needles, you remove and bin the needle after each dose and never re-cap or reuse it. Reusing needles blunts them and raises the risk of infection and site irritation. Our note on what to do with the pen after injecting covers the after-steps, and there's specific guidance on Mounjaro injection needles for the pen types that need them.
Keep the sharps bin out of reach of children and pets, and don't overfill it past the marked line. It's a small routine, but it protects you, your household and the people who handle waste. Once you've done it a couple of times, it becomes automatic, tacked on to the end of your weekly injection like any other habit.
Mounjaro isn't for everyone, and BMI alone never decides it. For private weight-management use, the licensed picture is broadly adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. Lower thresholds can apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under UK guidance.
Some people shouldn't take it. It isn't recommended in pregnancy, when breastfeeding, or if you're trying to conceive, and it isn't licensed for under-18s. A history of certain conditions, including pancreatitis and specific thyroid tumours, needs a proper conversation with a prescriber first. There's also a contraception point worth flagging: the MHRA advises women on oral contraceptives to add a barrier method, such as condoms, for the first four weeks of tirzepatide and for four weeks after each dose increase, because the pill's absorption may be reduced.
This is exactly why a prescriber, not a form, makes the call. When you look at the wider Mounjaro weight-loss injections or the main Mounjaro overview, the eligibility rules are the same. NICE also sets separate, stricter criteria for NHS use, which you can read in its appraisal of tirzepatide (TA1026).
The most common effects of the Mounjaro injection are digestive: feeling sick, being sick, diarrhoea, constipation, indigestion, burping, and sometimes tiredness or headache. They tend to show up most after starting or stepping up a dose, and for many people they ease within days to a couple of weeks. Injection-site reactions can happen too. Our page on Mounjaro injection side effects covers the full range.
Rarely, more serious problems occur. On 29 January 2026 the MHRA issued a Drug Safety Update reminding people that severe, persistent stomach pain that may spread to your back, with or without vomiting, can signal acute pancreatitis and needs urgent medical attention. Sudden gallbladder symptoms, signs of dehydration from bad sickness, or an allergic reaction also warrant prompt help.
You can report any suspected side effect through the MHRA Yellow Card scheme, which is worth doing even if you're not sure the medicine caused it. If you're unsure about anything you're feeling, ask. That's what a clinician-led service is for.
If the Mounjaro injection sounds like it might fit, the sensible next move is a proper assessment rather than a purchase. Speak to our prescribers about starting treatment, and they'll check whether it's clinically right for you.
Related questions we've answered
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.